Catherine Pachuk
Chief Tech/Sci/R&D Officer bei MARIZYME, INC.
Vermögen: 20 153 $ am 31.03.2024
Profil
Catherine J.
Pachuk is the founder of Nucleonics, Inc. founded in 2001.
Currently, she holds the position of Director & Chief Scientific Officer at Somahlution LLC since 2011 and Chief Science Officer at Marizyme, Inc. since 2020.
Dr. Pachuk holds a doctorate degree from the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MARIZYME INCORPORATED
0,58% | 20.06.2023 | 268 710 ( 0,58% ) | 20 153 $ | 31.03.2024 |
Aktive Positionen von Catherine Pachuk
| Unternehmen | Position | Beginn |
|---|---|---|
| MARIZYME, INC. | Chief Tech/Sci/R&D Officer | - |
Somahlution LLC
 Somahlution LLC Medical DistributorsDistribution Services Somahlution LLC provides medical products focused on ischemia reperfusion injury using patented and proprietary technologies. It offers DuraGraft, one time intraoperative vascular graft treatment that maintains endothelial function and structure. The company was founded by Vithalbhai Dhaduk and C. Satish Chandran in 2010 and is headquartered in Jupiter, FL. | Chief Tech/Sci/R&D Officer | 01.08.2011 |
Ehemalige bekannte Positionen von Catherine Pachuk
| Unternehmen | Position | Ende |
|---|---|---|
Nucleonics, Inc.
 Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA. | Founder | - |
Ausbildung von Catherine Pachuk
| University of Pennsylvania | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MARIZYME, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Nucleonics, Inc.
Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA. | Health Technology |
Somahlution LLC
Somahlution LLC Medical DistributorsDistribution Services Somahlution LLC provides medical products focused on ischemia reperfusion injury using patented and proprietary technologies. It offers DuraGraft, one time intraoperative vascular graft treatment that maintains endothelial function and structure. The company was founded by Vithalbhai Dhaduk and C. Satish Chandran in 2010 and is headquartered in Jupiter, FL. | Distribution Services |
